Creatine Aids Sleep-Deprived Cognition
- A recent study suggests a single dose of creatine may reduce cognitive declines from sleep deprivation. - Researchers called for future work to define optimal dosages across different populations and contexts. - The evidence is intriguing but preliminary, focused on cognition under sleep loss rather than athletic performance specifically. (nutraingredients.com)
Creatine is a compound the body uses to recycle energy, like a backup battery for cells, and two recent studies suggest a single dose may blunt some mental slowdown after a sleepless night. (pmc.ncbi.nlm.nih.gov) In a 2026 paper in *Nutrients*, researchers at Forschungszentrum Jülich tested 29 healthy subjects during 21 hours of sleep deprivation after a single dose of creatine monohydrate at 0.2 grams per kilogram of body weight or a placebo. (mdpi.com) The team measured performance at baseline, then 3, 5.5, and 7.5 hours later, and reported less decline on logical and numerical tasks, language-related processing speed, and the Psychomotor Vigilance Test, a standard reaction-time test used in sleep research. (mdpi.com) The paper said the lower dose produced improvements of up to 12% and that women in the study appeared to benefit more than men on logic, vigilance, and some processing-speed measures. (mdpi.com) That result followed a 2024 *Scientific Reports* study from the same research group, which gave 15 participants a higher single dose of 0.35 grams per kilogram during subtotal sleep deprivation and tracked both cognitive tests and brain-energy markers. (pmc.ncbi.nlm.nih.gov) That earlier study reported changes in phosphocreatine, adenosine triphosphate, total creatine, and brain pH alongside better cognitive performance and processing speed, with the research center saying effects appeared after about three hours, peaked around four hours, and lasted up to nine hours. (pmc.ncbi.nlm.nih.gov; fz-juelich.de) Creatine is better known as a sports supplement, but both papers focused on cognition under sleep loss, not on lifting, sprinting, or other athletic outcomes. (mdpi.com; pmc.ncbi.nlm.nih.gov) The researchers also drew a limit around the finding: the 2026 study tested a lower dose because the 2024 dose was high, and the Jülich team said high one-time doses should not be tried casually because they can strain the kidneys. (mdpi.com; fz-juelich.de) What happens next is narrower than the headlines. The 2026 paper called for more work to pin down the best dose for different people and settings, and for now the evidence points to a lab finding about sleep-deprived thinking, not a general prescription for everyday use. (mdpi.com)
